Clinical Trials Directory

Trials / Conditions / Stage III Ovarian Germ Cell Tumor

Stage III Ovarian Germ Cell Tumor

10 registered clinical trials studyying Stage III Ovarian Germ Cell Tumor.

StatusTrialSponsorPhase
WithdrawnMechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant
NCT01558778
Roswell Park Cancer InstituteN/A
CompletedVaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer
NCT01322802
University of WashingtonPhase 1
CompletedTemsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
NCT01155258
University of Southern CaliforniaPhase 1
CompletedQuality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
NCT01126346
Wake Forest University Health SciencesN/A
CompletedPhase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
NCT01037790
Abramson Cancer Center at Penn MedicinePhase 2
CompletedStereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignan
NCT01079832
Case Comprehensive Cancer CenterPhase 2
CompletedTemsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors
NCT00408655
National Cancer Institute (NCI)Phase 1
TerminatedEF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer
NCT00087191
National Cancer Institute (NCI)N/A
TerminatedImatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testic
NCT00042952
National Cancer Institute (NCI)Phase 2
CompletedVaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer
NCT00436254
University of WashingtonPhase 1